The recovery of rVSV involves the transfection of vaccinia-T7 infected cells with 4 (or 5) different plasmids; one that expresses the rVSV antigenome (e.g. pVSV-FL+(2) or pVSV-ΔG-GFP) and 3 (or 4) other plasmids that express the VSV N, P, and L proteins (or N, P, L and G for replication-restricte ΔG-VSV).
From the laboratory of Michael A. Whitt, Ph.D., University of Tennessee.
Part of The Investigator's Annexe program.
Product Type: | Plasmid |
Gene/insert name: | VSV nucleocapsid (N) protein; VSV phosphoprotein (P); VSV large polymerase subunit (L); VSV-Indiana glycoprotein (G) |
Antibiotic Resistance: | Ampicillin or Kanamycin (please see vial label and packing slip) |
Fusion Tag(s): | none |
Concentration: | 100uL (100ng/uL) |
Grow in E. coli at 37 C: | Yes |
Vector Backbone and Size: | pBS-SK-ΦT, 3105 bp |
High or low copy: | High |
Comments: | For suggested protocol, see: Whitt, MA, J. Virol. Methods, 2010. 169(2): p. 365-74. |
Shipped: | Ambient temperature |
If you publish research with this product, please let us know so we can cite your paper.